Orexo

Description

Orexo develops powder-based drug delivery technologies and therapeutic formulations, including AmorphOX®, used to improve bioavailability and stability for peptides and biologics for pharmaceutical partners and patients.

Related

• Nanoform Finland OyjNanoform Finland Oyj builds nanotechnology-enabled formulation and GMP manufacturing processes to improve bioavailability and drug loading…
• NanoPhoriaNanoPhoria develops an inhaled Nano-in-Micro delivery platform and formulations to deliver therapeutic peptides and RNAs for…
• EvotecEvotec provides integrated drug discovery and preclinical development services, delivering CRO/CDMO research platforms, ADME‑Tox, biologics…
• NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
• BiograilBiograil develops proprietary BIONDD® technology for oral delivery of biologics, using it in preclinical pharmaceutical work to turn…
• EnzyTagEnzyTag develops peptiligase-based synthetic routes for manufacturing peptide new chemical entities, small proteins, and peptide…
• GradientechGradientech develops the QuickMIC system for ultra-rapid phenotypic antibiotic susceptibility testing, producing precise MIC values for…
• ImmunAwareImmunAware supplies MHC class I molecules for custom monomers and tetramers, offers easYmers® to load peptides into custom peptide-MHC…
• APCAPC provides process development services and technology platforms that accelerate pharmaceutical and biologics development for pharma and…